Principles of Pharmacogenomics

BIOMEDIN224

Stanford School of Medicine


Thumbnail

Description

This introduction to pharmacology and genomics provides experimental and analytical methods for high-throughput measurements. A review of key gene classes, drugs for which genetics is critical and resources for pharmacogenomics will be discussed and analyzed. Explore issues in the clinical implementation of pharmacogenomics testing and read key papers by leaders in the field. There will be problem sets and a final project selected with approval of the instructor.

 

Prerequisites

Two of BIO41, 42, 43, 44X, 44Y or consent of instructor

Topics include

  • Key gene classes such as cytochromes and transporters
  • Pharmacogenomics resources: PharmGKB, Drugbank and NCBI
  • Key drugs: Warfarin, Clopidogrel, Statins and cancer drugs
  • Experimental methods: Sequencing, expression and genotyping

Notes

Course Availability

The course schedule is displayed for planning purposes – courses can be modified, changed, or cancelled. Course availability will be considered finalized on the first day of open enrollment. For quarterly enrollment dates, please refer to our graduate education section.

Pre-register Now

Dates:March 29 - June 4, 2021
Units: 3.00
Instructors:
Delivery Option:
Online
Fees:
For Credit $4,056.00
Notes: Pre-registration Dates: February 1, 2021 at 9:00am to March 12, 2021 at 5:00pm

Pre-registration for this course will secure your enrollment request and ensure timely processing of your application for potential course approval. Please note: course enrollment will be confirmed after March 19, 2021; after completing your pre-registration, no further action is required on your part.

 

This course may not currently be available to learners in some states and territories.